In vitro cellular and cytokine responses to mycobacterial antigens: Application to diagnosis of tuberculosis infection and assessment of response to mycobacterial vaccines

American Journal of the Medical Sciences

Volumn 313, Issue 6, 1997, Pages 364-371

  David Lein, A ^a,b   Von Reyn, C Fordham ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Cytokines; Delayed type hypersensitivity; Mycobacteria; Tuberculosis; Interferon

Indexed keywords

BCG VACCINE; CYTOKINE; GAMMA INTERFERON; HEAT SHOCK PROTEIN; MYCOBACTERIUM ANTIGEN; MYCOBACTERIUM VACCINE;

ARTICLE; CELLULAR IMMUNITY; DELAYED HYPERSENSITIVITY; HUMAN; IMMUNIZATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SKIN TEST; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0342601461     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199706000-00009     Document Type: Article

References (66)

1. von Reyn CF, Green PA, McCormick D, Huitt GA, Marsh BJ, Magnusson M, et al. Dual skin testing with Mycobacterium avium sensitin and purified protein deriviative: an open study of patients with M. aviuin complex infection or tuberculosis. Clin Infect Dis. 1994; 19:15-20.
2. Margileth AM. Editorial response: What is the diagnostic value of dual skin testing with tuberculous and nontuberculous mycobacterial antigens? Clin Infect Dis. 1994; 19:21-3.
3. Chaparas SD, Editorial response: Dual skin testing with Mycobacterium avium sensitin and purified protein derivative in patients with M. avium complex infection or tuberculosis. Clin Infect Dis. 1994; 19:24-5.
4. Rooney JJ, Crocco JA, Kramer S, Lyons HA. Further observations on tuberculin reactions in active tuberculosis. Ann Intern Med. 1968:731-44.
5. Nash DR, Douglas JE. Anergy in active pulmonary tuberculosis. Chest. 1980; 77:32-7.
6. Kim JH, Langston AA, Gallis HA. Miliary tuberculosis: Epidemiology, clinical manifestations, diagnosis, and outcome. Rev Infect Dis. 1990; 12:583-90.
7. Markowitz N, Hansen NI, Wilcosky TC, Hopewell PC, Glassroth J, Kvale PA, et al. Tuberculin and energy testing in HIV-seropositive and HIV-seronegative persons. Ann Intern Med. 1993; 119:185-93.
8. Ortals DW, Marr JJ. A comparative study of tuberculous and other mycobacterial infections and their associations with malignancy. Am Rev Respir Dis. 1978; 117:39-45.
9. Dorken E, Grzybowski S, Allen EA. Significance of the tuberculin test in the elderly. Chest. 1987; 92:237-40.
10. Battershill JH. Cutaneous testing in the elderly patient. Chest. 1980; 77:188-9.
11. Andrew OT, Schoenfeld PV, Hopeweil PC, Humphries MH. Tuberculosis in patients with end-stage renal disease. Am J Med. 1980; 68:L59-65.
12. Sahn SA, Lakshminarayan S. Tuberculosis after corticosteroid therapy. Br J Dis Chest. 1976; 70:195-205.
13. Fine PE. The BCG story: Lessons from the past and implications for the future. Rev Infect Dis. 1989;11(suppl 2):S353-9.
14. Smith DW. Protective effect of BCG in experimental tuberculosis. Adv Tuberc Res. 1985; 22:1-97.
15. Orme IM. Prospects for new vaccines against tuberculosis. Trends Microbiol. 1995; 3:401-4.
16. von Reyn CF, Arbeit RD, Yeaman G, Waddell RD, Marsh BJ, Morin P, et al. Immunization of healthy adult subjects in the United States with a three dose series of inactivated Mycobacterium vacce. Clin Inf Dis. In press.
17. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, et al. Defining protective responses to pathogens: Cytokine profiles in leprosy lesions. Science. 1991; 254:277-9.
18. Molloy A, Kaplan G. Cell-Mediated Immune Response. In: Rom W, Garay S, eds. Tuberculosis. Boston: Little. Brown and Company. 1996:305-14.
19. Ogawa T, Uclieda H, Kusumoto Y, Mori Y, Yamamura Y, Hamada S. Increase in tumor necrosis factor alpha and interleukin-6 secreting cells in peripheral hood mononuclear cells from subjects infected with Mycobacterium tuberculosis. Infect Immun. 1991; 59:3021-5.
20. Saha B, Das G, Vohra H, Ganguly NK, Mishra GC. Macrophage - T cell interaction in experimental mycobacterial infection. Selective regulation of co-stimulatory molecules and its implication in the suppression of cell-mediated immune response. Eur J Immunol. 1994; 24:2618-24.
21. Toossi Z, Sedor JR, Lapurge JP, Ondash RJ, Ellner JJ. Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis. J Clin Invest. 1990; 85:1777-84.
22. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell. 1989; 56:731-40.
23. Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med. 1992; 175:1111-22.
24. Barnes PF, Modlin RL, Ellner JJ. T-Cell Responses and Cytokines. In: Bloom BR, ed. Tuberculosis: Pathogenesis. Protection, and Control. Washington. DC: ASM Press. 1994:417-35.
25. Krowka JF, Cuevas B, Maron DC, Steimer KS, Ascher MS, Shepard HW. Expression of CD69 after in vitro stimulation: A rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 11:95-104.
26. Caruso A, Licenziati S, Corulli M, Canaris AD, De Francesco MA, Fiorentini S, et al. Flow cytomotric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry. 1997; 27:71-6.
27. Denis M. Growth of Mycobacterium aviuin in human monocytes: Identification of cytokines which reduce and enhance intracellular growth. Eur J Immunol 1991; 21:391-5.
28. Havlir DV, Wallis RS, Boom WH, Daniel TM, Chervenak K, Ellner JJ. Human immune response to Mycobacterium tuberculosis antigens. Infect Immun. 1991; 59:665-70.
29. Mehra V, Gong ,JH, Iyer D, Lin YG, Boylen CT, Bloom BR, et al. Immune response to recombinant mycobacterial proteins in patients with tuberculosis infection and disease. J Infect Dis. 1996; 174:431-4.
30. Fiavey NP, Frankenburg S. Appraisal of the total blood lymphocyte proliferation assay as a diagnostic tool in screening for tuberculosis. J Med Microbiol. 1992; 37:283-5.
31. McMurray DN, Echeverri A. Cell-mediated immunity in anergic patients with pulmonary tuberculosis. Am Rev Respir Dis. 1978; 118:827-34.
32. Huygen K, van Vooren J, Turneer M, Bosmans R, Dierckx P, De Bruyn J. Specific lymphoproliferation, gamma interferon production, and serum immunoglogulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in a patient with active tuberculosis. Scand J Immunol. 1988; 27:187.
33. Kemp EB, Belshe RB, Hoft DF. Immune responses stimulated by percutaneous and intradermal Bacille Calmelte-Gúerin. J Infect Dis. 1996; 174:113-9.
34. Ravn P, Boesen H, Pedersen BK, Andersen P. Human T cell responses induced by vaccination with M. bovis Bacillus Calmette-Gúerin. J Immunol. 1997; 158:1949-55.
35. Prussin C, Metcalfe DD. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods. 1995; 188:117-28.
36. Wood PR, Corner LA, Rothel JS, Baldock C, Jones SL, Cousins DB, et al. Field comparison of the interferon-gamma assay and the intradermal tuberculin test for the diagnosis of bovine tuberculosis. Aus Vet J. 1991; 68:286-90.
37. Wood PR, Rothel JS. In vitro immunodiagnostic assays for bovine tuberculosis. Vet Microbiol. 1994; 40:125-35.
38. Whipple DL, Bolin CA, David AJ, Jarnigan JJ, Johnson DC, Nabors RS, et al. Comparison of the sensitivity of the caudal fold skin test and a commercial gamma-interferon assay for diagnosis of bovine tuberculosis. Am J Vet Res. 1995; 56:415-9.
39. Streeton JA, Jones SL. Quanti FERON-TB: A new in vitro test for tuberculosis and atypical mycobacterial infection. Annual Scientific Meeting of the Australian Society for Microbiology. Canberra, 1995.
40. Davidson PM, Creati L, Wood PR, Roberton DM, Hosking CS. Lymphocyte production of gamma-interferon as a test for non-tuberculous mycobacterial lymphadenitis in children. Eur J Pediatr. 1993; 152:31-5.
41. Graham N. New approaches to screening for tuberculosis: tuberculin skin test versus in vitro interferon-gamma assay. Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, 1996.
42. Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 1994; 62:2536-44.
43. Guleria I, Teitelbaumm R, McAdam RA, Kalpana G, Jacobs WR Jr, Bloom BR. Auxotrophic vaccines for tuberculosis. Nature Medicine. 1996; 3:334-7.
44. Horwitz MA, Lee B-W, Dillon BJ, Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 1995; 92:1530-4.
45. Pal PG, Horwitz MA. Immunization with extracellular proteins of M. tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun. 1992; 60: 4781-92.
46. Andersen P, Askgaard D, Ljungqvist L, Bentzon MW, Heron I. T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun. 1991; 59: 1905-10.
47. Young DB, Kaufmann SHE, Hermans Thole JER. Mycobacterial protein antigens: a compilation. Mol Microbiol. 1992; 6:133-45.
48. Mehra V, Bloom BR, Bajardi AC, Grisso CL, Sieling PA, Alland D, et al. A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. J Exp Med. 1992; 175:275-84.
49. Barnes PF, Mehra V, Rivoire B, Fong SJ, Brennan PJ, Voegtline MS, et al. Immunoreactivity of a 10-kDa antigen of Mycobacterium tuberculosis. J Immunol. 1992; 148:1835-40.
50. Harboe M, Quayle AJ. Heat shock proteins: Friend or foe? Clin Exp Immunol. 1991; 86:2-5.
51. Orme IM. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance, in mice inoculated with killed mycobacterial vaccines. Infect Immun. 1988; 56:3310-2.
52. Rook GAW, Steele J, Barnass S, Mace J, Stanford JL. Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donors. Clin Exp Immunol. 1986; 63:105-10.
53. Orme IM, Miller ES, Roberts AD, Furney SK, Griffin JP, Dobos KM, et al. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J Immunol. 1992; 148:189-96.
54. Andersen P, Heron I, Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect. Immun. 1993; 61:844-51.
55. Andersen P, Askgaard D, Gottschau A, Bennedsen J, Nagai S, Heron I. Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol. 1992; 36:823-31.
56. Roche PW, Tricca JA, Avery DA, Fifis T, Billman-Jacobe H, Britton WJ. Differential T-cell responses to mycobacterial secreted proteins distinguish between Bacillus Camille-Gúerin vaccination and infection with Mycobacterium tuberculosis. J Infect Dis. 1994; 170:1326-30.
57. Roche PW, Winter N, Triccas JA, Feng CG, Britton WJ. Expression of Mycobacterium tuberculosis MPT64 in recombinant Myco. smegmatis: purification, immunogenicity, and application to skin tests for tuberculosis. Clin Exp Immunol. 1996; 103:226-32.
58. Surcel MM, Troye-Blomberg M, Paulie S, Andersson G, Moreno C, Pasvol G, Ivanyi J. Thl/Th2 profiles in tuberculosis based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology. 1994; 81:171-6.
59. Andersen P, Andersen AB, Sørensen AL, Nagai S. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol. 1995; 154:3359-72.
60. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun. 1996; 64:16-22.
61. Cox RA, Lundberg DI, Arnold DR. Lymphocyte transformation assays as a diagnostic tool in tuberculosis of children. Am Rev Respir Dis. 1981; 123:627-30.
62. Tager IB, Kalaidjian R, Baldini L, Rocklin RE. Variability in the intradermal and in vitro lymphocyte responses to PPD in patients receiving isoniazid prophylaxis. Am Rev Respir Dis. 1985; 131:214-20.
63. Sánchez FO, Rodriguez JI, Agudelo G, Garcia LF, Immune responsiveness and lymphokine production in patients with tuberculosis and health controls. Infect Immun. 1994; 62:5673-8.
64. Zhang M, Lin YG, Iyer DV, Gong JH, Abrams JS, Barnes PF. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun. 1995; 63:3231-4.
65. Vidal S, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites. Isolation of a candidate for beg. Cell. 1993; 73:469-85.
66. Petrovsky N, McNair P, Harrison LC. Circadian rhythmicity of interferon-gamma production in antigen stimulated whole blood. Chronobiologia. 1994; 21:293-300.